Literature DB >> 9799180

Relation of time since last birth and parity to survival of young women with breast cancer.

S H Olson1, A G Zauber, J Tang, S Harlap.   

Abstract

We investigated whether survival was related to recent childbirth or parity in a cohort of 540 women diagnosed with breast cancer before the age of 45 years who were followed for up to 14 years. Women who had given birth within 2 years before their diagnosis of breast cancer were at increased risk of dying, compared with nulliparous women, with an adjusted relative risk of 3.1 (95% confidence interval = 1.8-5.4). There was a moderate association of parity with mortality, with an adjusted relative risk of 1.8 (95% confidence interval = 1.2-2.9) for women with three or more births, compared with nulliparous women.

Entities:  

Mesh:

Year:  1998        PMID: 9799180

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  20 in total

1.  Multiple births and breast cancer prognosis: a population based study.

Authors:  Lukman Thalib; Suhail A R Doi; Per Hall
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  Mammary gland involution as an immunotherapeutic target for postpartum breast cancer.

Authors:  Jaime Fornetti; Holly A Martinson; Courtney B Betts; Traci R Lyons; Sonali Jindal; Qiuchen Guo; Lisa M Coussens; Virginia F Borges; Pepper Schedin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-22       Impact factor: 2.673

3.  Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis.

Authors:  S Warren Andersen; P A Newcomb; J M Hampton; L Titus-Ernstoff; K M Egan; A Trentham-Dietz
Journal:  Breast Cancer Res Treat       Date:  2011-07-19       Impact factor: 4.872

4.  Impact of Time Since Last Childbirth on Survival of Women with Premenopausal and Postmenopausal Breast Cancers.

Authors:  Nanthini Balakrishnan; Soo-Hwang Teo; Siamala Sinnadurai; Nanthini Thevi Bhoo Pathy; Mee-Hoong See; Nur Aishah Taib; Cheng-Har Yip; Nirmala Bhoo Pathy
Journal:  World J Surg       Date:  2017-11       Impact factor: 3.352

5.  Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women.

Authors:  Laura C Collins; Shari Gelber; Jonathan D Marotti; Sarah White; Kathryn Ruddy; Elena F Brachtel; Lidia Schapira; Steven E Come; Virginia F Borges; Pepper Schedin; Ellen Warner; Taylor Wensley; Rulla M Tamimi; Eric P Winer; Ann H Partridge
Journal:  Oncologist       Date:  2015-05-29

6.  Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study.

Authors:  Avonne E Connor; Kala Visvanathan; Kathy B Baumgartner; Richard N Baumgartner; Stephanie D Boone; Lisa M Hines; Roger K Wolff; Esther M John; Martha L Slattery
Journal:  Breast Cancer Res Treat       Date:  2016-11-11       Impact factor: 4.872

7.  Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis.

Authors:  Kathrin Strasser-Weippl; Ritesh Ramchandani; Lei Fan; Junjie Li; Marc Hurlbert; Dianne Finkelstein; Zhi-Ming Shao; Paul E Goss
Journal:  Breast Cancer Res Treat       Date:  2014-12-14       Impact factor: 4.872

Review 8.  The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis.

Authors:  Jessica McCready; Lisa M Arendt; Jenny A Rudnick; Charlotte Kuperwasser
Journal:  Breast Cancer Res       Date:  2010-06-17       Impact factor: 6.466

Review 9.  Breast cancer diagnosis during pregnancy.

Authors:  Jennifer K Litton; Richard L Theriault; Ana M Gonzalez-Angulo
Journal:  Womens Health (Lond)       Date:  2009-05

10.  Association of Parity and Time since Last Birth with Breast Cancer Prognosis by Intrinsic Subtype.

Authors:  Xuezheng Sun; Hazel B Nichols; Chiu-Kit Tse; Mary B Bell; Whitney R Robinson; Mark E Sherman; Andrew F Olshan; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-06       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.